Publications

Click to view citations

Books

  1. D.J. Burgess. Injectable Dispersed Systems, Formulation, Processing and Performance. Ed. D.J. Burgess, Drugs and The Pharmaceutical Sciences Series, Marcel Dekker, New York, (2005).
  2. J. Wright and D.J. Burgess: Controlled Release Science and Technology: Long Acting Injections and Implants, CRS Press, Springer, New York, 2012 http://dx.doi.org/10.1007/978-1-4614-0554-2

Recent Articles

  1. N. Malavia, Q. Bao, D.J. Burgess, Novel dissolution methods for drug release testing of Long-Acting injectables. Int. J. Pharm. 2024, 664:0378-5173. https://doi.org/10.1016/j.ijpharm.2024.124634
  2. S. Kharea, R. Jog, A. Bright, D.J. Burgess, S.K. Chakder and K. Gokulan. Evaluation of mucosal immune profile associated with Zileuton nanocrystal-formulated BCS-II drug upon oral administration in Sprague Dawley rats. Nanotoxicology. 2023,17(10):583-603. https://doi.org/10.1080/17435390.2023.2289940
  3. Y. Huang, S. Liangpunsakul, S. Rudraiah, J. Ma, S.K. Keshipeddy, D. Wright, A. Costa, D.J. Burgess, Y. Zhang, N. Huda, L. Wang, Z. Yang. HMGB2 is a potential diagnostic marker and therapeutic target for liver fibrosis and cirrhosis. Hepatol Commun. 7(11):e0299,Nov. 2023. https://doi.org/10.1097/HC9.0000000000000299
  4. X. Wang, Q. Bao, R. Wang, O. Kwok, K. Maurus, Y. Wang, B. Qin, D.J. Burgess. In situ forming risperidone implants: Effect of PLGA attributes on product performance. J. Controlled Release., 2023, 361:777-791. https://doi.org/10.1016/j.jconrel.2023.08.029
  5. X. Wang, Q. Bao, R. Wang, T. Li, Y. Wang, B. Qin, Q. Li, D.J. Burgess. In vivo characterization of Perseris and compositionally equivalent formulations. Int. J. Pharm. 2023, 642:123170. https://doi.org/10.1016/j.ijpharm.2023.123170
  6. A.G. Clark, R. Wang, J. Lomeo, Y. Wang, A. Zhu, M. Shen, Q. Bao, D.J. Burgess, B. Qin, S. Zhang. Investigating structural attributes of drug encapsulated microspheres with quantitative X-ray imaging. J. Controlled Release. 2023, 358:626-635. https://doi.org/10.1016/j.jconrel.2023.05.019
  7. B. Wan, Q. Bao, D.J. Burgess. Long-acting PLGA microspheres: advances in excipient and product analysis toward improved product understanding. Advanced Drug Delivery Reviews. 2023, 198:114857. https://doi.org/10.1016/j.addr.2023.114857
  8. X. Wang, Q. Bao, R. Wang, B. Wan, Y. Wang, B. Qin, D.J. Burgess. Reverse engineering of Perseris and development of compositionally equivalent formulations. Int. J. Pharm. 2023, 639: 122948. https://doi.org/10.1016/j.ijpharm.2023.122948 hk
  9. R. Holm, R.W. Lee, J. Glassco, N. DiFranco, Q. Bao, D.J. Burgess, V. Lukacova, S. Alidori. Long-acting injectable aqueous suspensions – Summary from an AAPS workshop. AAPS J. 2023, 25(3):49. doi: 10.1208/s12248-023-00811-8
  10. Q. Bao, X. Wang, B. Wan, Y. Zou, Y. Wang, D.J. Burgess. Development of in vitro-in vivo correlations for long-acting injectable suspensions. Int. J. Pharm. 2023, 634:122642. https://doi.org/10.1016/j.ijpharm.2023.122642
  11. R.H. Gudlavalleti, X. Xi, A. Legassey, P.Y. Chan, J. Li, D.J. Burgess, C. Giardina, F. Papadimitrakopoulos and F. Jain. Highly Miniaturized, Low-Power CMOS ASIC Chip for Long-Term Continuous Glucose Monitoring. Journal of Diabetes Science and Technology. 2023, Feb 11:19322968231153419. https://doi.org/10.1177/19322968231153419
  12. R. Kulkarni, S. Fanse, D.J. Burgess. Mucoadhesive drug delivery systems: a promising non-invasive approach to bioavailability enhancement. Part I: biophysical considerations. Expert Opinion on Drug Delivery. 2023, 20(3):395-412. https://doi.org/10.1080/17425247.2023.2181331
  13. R. Kulkarni, S. Fanse, D.J. Burgess. Mucoadhesive drug delivery systems: a promising non-invasive approach to bioavailability enhancement. Part II: formulation considerations. Expert Opinion on Drug Delivery. 2023, 20(3):413-434. https://doi.org/10.1080/17425247.2023.2181332
  14. Q. Bao, S. Fanse, X. Lu, D.J. Burgess. Impact of drug loading on release from levonorgestrel intrauterine systems. Int. J. Pharm. 2022, 631:122532. https://doi.org/10.1016/j.ijpharm.2022.122532
  15. S. Fanse, Q. Bao, D.J. Burgess. Long-acting intrauterine systems: Recent advances, current challenges, and future opportunities. 2022, Advanced Drug Delivery Reviews, 191:114581. https://doi.org/10.1016/j.addr.2022.114581
  16. X. Wang, Q. Bao, A.G. Clark, Y. Wang, S. Zhang, D.J. Burgess. Characterization and in vitro release of minocycline hydrochloride microspheres prepared via coacervation. Int. J. Pharm. 2022, 628:122292. https://doi.org/10.1016/j.ijpharm.2022.122292
  17. A.G. Clark, R. Wang, Y. Qin, Y. Wang, A. Zhu, J. Lomeo, Q. Bao, D.J. Burgess, J. Chen, B. Qin, Y. Zou, S. Zhang. Assessing microstructural critical quality attributes in PLGA microspheres by FIB-SEM analytics. J. Controlled Release. 2022, 349:580–591. https://doi.org/10.1016/j.jconrel.2022.06.066
  18. Wan, Q. Bao, R. Wang, D.J. Burgess. Polymer source affects in vitro-in vivo correlation of leuprolide acetate PLG microspheres. Int. J. Pharm. 2022, 625:122032. https://doi.org/10.1016/j.ijpharm.2022.122032
  19. Wang, Q. Bao, M.S. Suh, M. Kastellorizios, R. Wang, D.J. Burgess. Novel adapter method for in vitro release testing of in situ forming implants. Int. J. Pharm. 2022, 621:121777. https://doi.org/10.1016/j.ijpharm.2022.121777
  20. Bao, X. Wang, Y. Zou, Y. Wang, D.J. Burgess. In vitro release testing method development for long-acting injectable suspensions. Int. J. Pharm. 2022, 622:121840. https://doi.org/10.1016/j.ijpharm.2022.121840
  21. Wan, Q. Bao, D.J. Burgess. In vitro-in vivo correlation of PLGA microspheres: Effect of polymer source variation and temperature. Journal of Controlled Release. 2022, 347:347–355. https://doi.org/10.1016/j.jconrel.2022.05.014
  22. Yenduri, A.P. Costa, X. Xu, D.J. Burgess. Impact of critical process parameters and critical material attributes on the critical quality attributes of liposomal formulations prepared using continuous processing. Int. J. Pharm. 2022, 619:121700. https://doi.org/10.1016/j.ijpharm.2022.121700
  23. Duran, A. Costa, A. Gupta, X. Xu, H. Zhang, D.J. Burgess, B. Chaudhuri. Coarse-Grained Molecular Dynamics Simulations of Paclitaxel-Loaded Polymeric Micelles. Molecular pharmaceutics. 2022, 19(4):1117-1134. https://doi.org/10.1021/acs.molpharmaceut.1c00800
  24. Li, B. Wan, R. Jog, A. Costa, D.J. Burgess. Pectin microparticles for peptide delivery: Optimization of spray drying processing. Int. J. Pharm. 2022, 613:121384. https://doi.org/10.1016/j.ijpharm.2021.121384
  25. S. Fanse. Q. Bao. Y. Zou. Y. Wang. D.J. Burgess. Impact of polymer crosslinking on release mechanisms from long-acting levonorgestrel intrauterine systems. Int. J. Pharm. 2022, 612:121383. https://doi: 10.1016/j.ijpharm.2021.121383
  26. He, E. Renard, P. Lord, D. Cohen, B. Gu, X. Wang, G. Yenduri, D.J. Burgess. Strategies for extended lifetime of implantable intraperitoneal insulin catheters. J. Controlled Release. 2022, 341:487-497. https://doi.org/10.1016/j.jconrel.2021.11.038
  27. Wan, Q. Bao, Y. Zou, Y. Wang, D.J. Burgess. Effect of polymer source variation on the properties and performance of risperidone microspheres Int. J. Pharm. 2021, 610:121265. https://doi.org/10.1016/j.ijpharm.2021.121265
  28. Fanse, Q. Bao, Y. Zou, Y. Wang, D.J. Burgess. Effect of crosslinking on the physicochemical properties of polydimethylsiloxane-based levonorgestrel intrauterine systems. Int. J. Pharm. 2021, 609:121192. https://doi.org/10.1016/j.ijpharm.2021.121192
  29. Wang, D.J. Burgess. Drug release from in situ forming implants and advances in release testing. Advanced Drug Delivery Reviews, 2021, 178:113912. https://doi.org/10.1016/j.addr.2021.113912
  30. He, E. Renard, P. Lord, D. Cohen, E. Cem-Duranty, J. Place, B. Gu, X. Wang, G. Yenduri, D.J. Burgess. Root cause determination of intraperitoneal catheter obstructions: Insulin amyloid aggregates vs foreign body reaction. J. Controlled Release. 2021, 336:1-15. https://doi.org/10.1016/j.jconrel.2021.06.005
  31. B Wan, J.V. Andhariya, Q Bao, Y Wang, Y Zou, J. Burgess. Effect of polymer source on in vitro drug release from PLGA microspheres. Journal of Pharmaceutics, 2021, 607. https://doi.org/10.1016/j.ijpharm.2021.120907
  32. Gupta, A.P. Costa, X. Xu, and D.J. Burgess. Continuous processing of Paclitaxel polymeric micelles. Int. J. Pharm. 2021, 607:120946. https://doi.org/10.1016/j.ijpharm.2021.120946
  33. Sansare, T. Duran, H. Mohammadiarani, M. Goyal, G. Yenduri, A. Costa, X. Xu, T. O’Connor, D.J. Burgess, B. Chaudhuri. Artificial neural networks in tandem with molecular descriptors as predictive tools for continuous liposome manufacturing. Int. J. Pharm. 2021, 603:120713. https://doi.org/10.1016/j.ijpharm.2021.120713
  34. Ochi, B. Wan, Q. Bao and D.J. Burgess. Influence of PLGA molecular weight distribution on leuprolide release from microspheres. Int. J. Pharm. 2021, 599:120450. https://doi.org/10.1016/j.ijpharm.2021.120450
  35. Bao, Y. Zou, Y. Wang, S. Choi, D.J. Burgess. Impact of formulation parameters on in vitro release from long-acting injectable suspensions. The AAPS Journal, March 2021, 23:42. https://doi.org/10.1208/s12248-021-00566-0
  36. Li and D.J. Burgess. Biomarker monitoring and long-acting insulin treatment in a stress model to facilitate personalized diabetic control. Journal of Controlled Release. 2021, 332:21–28. https://doi.org/10.1016/j.jconrel.2021.02.013
  37. Li, R.V. Lalla, and D.J. Burgess. Enhanced drug loading of in situ forming gels for oral mucositis pain control. Int. J. Pharm. 2021, 595:12022. https://doi.org/10.1016/j.ijpharm.2021.120225
  38. S. Suh, M. Kastellorizios, N. Tipnis, Y. Zou, Y. Wang, S. Choi, and D.J. Burgess. Effect of implant formation on drug release kinetics of in situ forming implants. Int. J. Pharm. 2021, 592:120105. https://doi.org/10.1016/j.ijpharm.2020.120105
  39. Tipnis, M. Kastellorizios, A. Legassey, F. Papadimitrakopoulos, F. Jain, D.J. Burgess. Sterilization of drug-loaded composite coatings for implantable glucose biosensors. J Diabetes Science and Technology. 2021, 15(3)646-654. https://doi.org/10.1016/j.jconrel.2019.10.01410.1177/1932296819890620
  40. Lu, B. Ning, N. Fotaki, S.S. Sharp, D.J. Burgess and S. Haddouchi. American Association of Pharmaceutical Scientists (AAPS) and Chinese National Institutes for Food and Drug Control (NIFDC) joint workshop on dissolution, bioequivalence, product performance, and quality. Dissolution Technologies, May 2020. https://dx.doi.org/10.14227/DT270220P42
  41. Li, D.J. Burgess. Nanomedicine based drug delivery towards tumor biological and immunological microenvironment. ACTA PHARM SIN B. 2020, 10(11):2110-2124. https://doi.org/10.1016/j.apsb.2020.05.008
  42. Bao, M.D. Morales-Acosta, D.J. Burgess. Physicochemical attributes of white petrolatum from various sources used for ophthalmic ointment formulations. Int. J. Pharm. 2020, 583:119381. https://doi.org/10.1016/j.ijpharm.2020.119381
  43. Gupta, A.P. Costa, X. Xu, S.L. Lee, C.N Cruz, Q. Bao, D.J. Burgess. Formulation and characterization of curcumin loaded polymeric micelles produced via continuous processing. Int. J. Pharm. 2020, 583:119340. https://doi.org/10.1016/j.ijpharm.2020.119340
  44. Kohno, J.V. Andhariya, B. Wan, Q. Bao, S. Rothstein, M. Hezel, Y. Wang, D.J. Burgess. The effect of PLGA molecular weight differences on risperidone release from microspheres. Int. J. Pharm. 2020, 582:119339. https://doi.org/10.1016/j.ijpharm.2020.119339
  45. Li, Q. Bao, J. Shen, R.V. Lalla, D.J. Burgess. Mucoadhesive in situ forming gel for oral mucositis pain control. Int. J. Pharm. 2020, 580:119238. https://doi.org/10.1016/j.ijpharm.2020.119238
  46. P. Tipnis, J. Shen, D. Jackson, D. Leblanc, D.J. Burgess. Flow-through cell-based in vitro release method for triamcinolone acetonide poly (lactic-co-glycolic) acid microspheres. Int. J. Pharm. 2020, 579:119130. https://doi.org/10.1016/j.ijpharm.2020.119130
  47. Bao. Y. Zou. Y. Wang S. Choi. D.J. Burgess. Impact of product design parameters on in vitro release from intrauterine systems. Int. J. Pharm. 2020, 578:119135. https://doi.org/10.1016/j.ijpharm.2020.119135
  48. Bao. Y. Zou, Y. Wang, D. Kozak, S. Choi, D.J. Burgess. Drug release testing of long-acting intrauterine systems. J. Controlled Release. 2019, 316:349–358. https://doi.org/10.1016/j.jconrel.2019.11.015
  49. V. Andhariya, R. Jog, J. Shen, S. Choi, Y. Wang, Y. Zou, D.J. Burgess. In vitro-in vivo correlation of parenteral PLGA microspheres: Effect of variable burst release. J. Control Release. 2019, 314:25-37. https://doi.org/10.1016/j.jconrel.2019.10.014
  50. V. Andhariya, R. Jog, J. Shen, S. Choi, Y. Wang, Y. Zou, D.J. Burgess. Development of level A in vitro-in vivo correlations for peptide loaded PLGA microspheres. J. Controlled Release, 2019, 308: 1-13. https://doi.org/10.1016/j.jconrel.2019.07.013
  51. Wang, N. Meng, S. Wang, Y. Zhang, L. Lu, R. Wang, H. Ruan, K. Jiang, H. Wang, D. Ran, C. Zhan, K. Yu, D.J. Burgess, W. Lu. Non-immunogenic, low-toxicity and effective glioma targeting MTI-31liposomes. J. Controlled Release. 2019, 316:381–392. https://doi.org/10.1016/j.jconrel.2018.12.003
  52. R. Pace, R. Jog, D.J. Burgess, M.K. Hadden. Formulation and evaluation of itraconazole liposomes for Hedgehog pathway inhibition. Journal of Liposome Research. 2019, Oct 2:1-7. https://doi.org/10.1080/08982104.2019.1668011
  53. V.Andhariya, J. Shen, Y. Wang, S. Choi, D.J. Burgess. Effect of minor manufacturing changes on stability of compositionally equivalent PLGA microspheres. Int. J. Pharm. 2019, 566:532-540. https://doi.org/10.1016/j.ijpharm.2019.06.014
  54. Jog, D.J. Burgess. Comprehensive quality by design approach for stable nanocrystalline drug products. Int. J. Pharm. 2019, 564:426-460. https://doi.org/10.1016/j.ijpharm.2019.04.050
  55. Cui, C.M. O’Connell, A. Costa, Y. Pan, J.A. Smyth, Paulo, H. Verardi, D.J. Burgess, Herbert J. Van Kruiningen, A.E. Garmendia. A PRRSV GP5-Mosaic vaccine: Protection of pigs from challenge and ex vivo detection of IFNγ responses against several genotype 2 strains. PLos One. 2019, 14(1):e0208801. https://doi.org/10.1371/journal.pone.0208801
  56. Wang, H. Wang, K. Jiang, Y. Zhang, C. Zhan, M. Ying, M. Zhang, L. Lu, R. Wang, S. Wang, D.J. Burgess, H. Wang, W. Lu. Liposomes with cyclic RGD peptide motif triggers acute immune response in mice. J. Controlled Release. 2019, 293:201–214. https://doi.org/10.1016/j.jconrel.2018.12.003
  57. Bao, D.J. Burgess. Perspectives on physicochemical and in vitro profiling of ophthalmic ointments. Pharmaceutical Research. 2018, 35:234. https://doi.org/10.1007/s11095-018-2513-3
  58. Jog, D.J. Burgess. Nanoamorphous drug products — design and development. Int. J. Pharm. 2018, 553:238-260. https://doi.org/10.1016/j.ijpharm.2018.10.046
  59. Gu, F. Papadimitrakopoulos, D.J. Burgess. PLGA microsphere/PVA hydrogel coatings suppress the foreign body reaction for 6 months. J. Controlled Release. 2018, 289:35-43. https://doi.org/10.1016/j.jconrel.2018.09.021
  60. Bao, Bing Gu, Claire F. Price, Yuan Zou, Yan Wang, Darby Kozak, Stephanie Choi, D.J. Burgess. Manufacturing and characterization of long-acting levonorgestrel intrauterine systems. Int. J. Pharm. 2018, 550:447–454. https://doi.org/10.1016/j.ijpharm.2018.09.004
  61. Bao, B. Newman, Y. Wang, S. Choi, D.J. Burgess. In vitro and ex vivo correlation of drug release from ophthalmic ointments. J. Control Release. 2018, 276:93–101. https://doi.org/10.1016/j.jconrel.2018.03.003
  62. Tipnis and D.J. Burgess. Sterilization of implantable polymer-based medical devices: A review, Int. J. Pharm. 2018. 544:455-460. https://doi.org/10.1016/j.ijpharm.2017.12.003